Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) FCF Margin (2024 - 2025)

Historic FCF Margin for Pyxis Oncology (PYXS) over the last 2 years, with Q2 2025 value amounting to 612.16%.

  • Pyxis Oncology's FCF Margin changed N/A to 612.16% in Q2 2025 from the same period last year, while for Sep 2025 it was 2566.13%, marking a year-over-year change of. This contributed to the annual value of 358.66% for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Pyxis Oncology's FCF Margin stood at 612.16%.
  • Over the past 5 years, Pyxis Oncology's FCF Margin peaked at 129.73% during Q1 2024, and registered a low of 612.16% during Q2 2025.